Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Whole Genome Sequencing of Patients with Myelodysplastic Syndrome Uncovers Novel, Clinically Relevant Biomarkers Missed by Standard Of Care Methods

MDS - 1210

Whole Genome Sequencing of Patients with Myelodysplastic Syndrome Uncovers Novel, Clinically Relevant Biomarkers Missed by Standard Of Care Methods

Alex Bataller

Poster Presenter: Alex Bataller

Thumbnail for Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

AML - 336

Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

Tapan Giri

Poster Presenter: Tapan Giri

Previous 1...138 139 140 141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial$

ABCL - 983

Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial

Nirav Shah

Poster Presenter: Nirav Shah

$Thumbnail for Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis$

CLL - 1061

Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis

Subodh Mathew

Poster Presenter: Subodh Mathew

Thumbnail for Ziftomenib combined with intensive induction (7+3) for newly diagnosed NPM1-m or KMT2A-r acute myeloid leukemia (AML): Long-term results from the KOMET-007 trial

AML - 1217

Ziftomenib combined with intensive induction (7+3) for newly diagnosed NPM1-m or KMT2A-r acute myeloid leukemia (AML): Long-term results from the KOMET-007 trial

Amer M Zeidan

Poster Presenter: Amer M Zeidan

Thumbnail for “EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study"

AML - 256

“EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study"

Juliana Faleschini

Poster Presenter: Juliana Faleschini

Thumbnail for “STAG2-Mutated MDS: Not Only Loss-of-Function?"

MDS - 1116

“STAG2-Mutated MDS: Not Only Loss-of-Function?"

Gloria Andreossi

Poster Presenter: Gloria Andreossi

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.